Mehrotra Biotech Profile
Key Indicators
- Authorised Capital ₹ 2.50 M
as on 16-11-2024
- Paid Up Capital ₹ 0.10 M
as on 16-11-2024
- Company Age 14 Year, 9 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 12.51 Cr
as on 16-11-2024
- Satisfied Charges ₹ 3.62 Cr
as on 16-11-2024
- Revenue 21.14%
(FY 2023)
- Profit -52.95%
(FY 2023)
- Ebitda -33.26%
(FY 2023)
- Net Worth 13.01%
(FY 2023)
- Total Assets -0.57%
(FY 2023)
About Mehrotra Biotech
The Company is engaged in the Life Sciences Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 2.50 M and a paid-up capital of Rs 0.10 M.
The company currently has active open charges totaling ₹12.51 Cr. The company has closed loans amounting to ₹3.62 Cr, as per Ministry of Corporate Affairs (MCA) records.
Gauri Mehrotra, Shilpa Mehrotra, Devesh Mehrotra, and One other member serve as directors at the Company.
- CIN/LLPIN
U24110UP2010PTC039957
- Company No.
039957
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
23 Mar 2010
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Kanpur
Industry
Company Details
- Location
Lucknow, Uttar Pradesh, India
- Telephone
- Email Address
- Website
- Social Media
What products or services does Mehrotra Biotech Private Limited offer?
Mehrotra Biotech Private Limited offers a wide range of products and services, including Laboratory & Lab Equipment, Laboratory Chamber, Strapping & Sealing Machines, Bag Sealer, Autoclaves, Sterilizers & Incubators, Medical Refrigerator Systems, Plant Growth Chambers, Laboratory Shakers, Laboratory Autoclave & Sterilizers, Chemical Plants & Machinery.
Who are the key members and board of directors at Mehrotra Biotech?
Board Members(4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Devesh Mehrotra  | Director | 23-Mar-2010 | Current |
| Gauri Mehrotra | Director | 23-Mar-2010 | Current |
| Shilpa Mehrotra | Director | 23-Mar-2010 | Current |
| Vinod Mehrotra | Director | 23-Mar-2010 | Current |
Financial Performance of Mehrotra Biotech.
Mehrotra Biotech Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 21.14% increase. The company also saw a substantial fall in profitability, with a 52.95% decrease in profit. The company's net worth Soared by an impressive increase of 13.01%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Mehrotra Biotech?
In 2023, Mehrotra Biotech had a promoter holding of 65.00% and a public holding of 35.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Hdfc Bank Limited Creation Date: 20 Mar 2023 | ₹1.00 Cr | Open |
Others Creation Date: 12 Dec 2022 | ₹1.50 Cr | Open |
Hdfc Bank Limited Creation Date: 27 Jun 2022 | ₹2.50 M | Open |
How Many Employees Work at Mehrotra Biotech?
Mehrotra Biotech has a workforce of 2 employees as of Apr 06, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Mehrotra Biotech, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Mehrotra Biotech's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
